Retroviral vaccines: Challenges for the developing world

AIDS Research and Human Retroviruses

Volumn 12, Issue 5, 1996, Pages 361-363

  Essex, M ^a  

^a Harvard AIDS Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOLOGICAL ADJUVANT; LIVE VACCINE; POLYPHOSPHAZENE; SAPONIN; UNCLASSIFIED DRUG;

CLINICAL TRIAL; CONFERENCE PAPER; DEVELOPING COUNTRY; DRUG CROSS REACTIVITY; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; PHENOTYPE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VIRUS TRANSMISSION;

EID: 0029978078     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.361     Document Type: Conference Paper

References (0)